Elinzanetant Safe, Effective for Moderate-to-Severe Vasomotor Symptoms
Benefits seen in frequency and severity, as well as menopause-related quality of life
FDA Approves Inluriyo for Advanced Breast Cancer
Approval is for adults with ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer
AAP: TikTok ‘Benadryl Challenge’ Fueling Rise in Diphenhydramine-Related Adverse Events
Monthly diphenhydramine-related adverse event reports ranged from 2.13 to 6.62 from May 2020 to December 2024
One Dose of Benzathine Penicillin G Noninferior to Three Doses for Syphilis
One dose was noninferior to three doses for serologic response at six months among patients with early syphilis
Loss of Therapeutic Benefit Seen After Stopping Baricitinib in Type 1 Diabetes
Author says findings support previous clinical trial data showing efficacy of baricitinib in preserving beta cell function in T1D
Antithymocyte Globulin Cuts Loss of β-Cell Function in Type 1 Diabetes
ATG 2.5 and 0.5 mg/kg reduces loss of β-cell function in young people with recent-onset type 1 diabetes
Kennedy Says FDA Reviewing Safety of Abortion Pill Mifepristone
FDA Approves Opzelura for Atopic Dermatitis in Children
It is the first topical JAK inhibitor approved in the U.S. for pediatric atopic dermatitis
Tylenol Refutes Old Post as Pregnancy Safety Debate Resurfaces
Doctors stress untreated fever can pose greater risks to mothers and babies
Gene Therapy Slows Huntington’s Disease in Early Trial
If approved, this would be the first genetic therapy for Huntington’s disease
